Tag Archives: Small Times Magazine

May 12, 2006 – Apogee Technology Inc. (AMEX: ATA), a micro-electrical mechanical systems and nanotechnology company that designs, develops and markets medical devices and sensors products, announced the formation of a Medical Advisory Board and the appointment of its first three members.

Peter Carroll has been appointed chairman of the advisory board. He is the founder of Medlen & Carroll, LLP. Carroll is joined by Joachim Kohn, the current Director of the New Jersey Center for Biomaterials, and Sanford Simon, Professor of Biochemistry, Cell Biology and Pathology at Stony Brook University.

May 11, 2006 – Rensselaer Polytechnic Institute, in collaboration with IBM and New York state, has announced a $100 million partnership to create a powerful university-based supercomputing center dedicated to nanotechnology.

The Computational Center for Nanotechnology Innovations (CCNI), based on the Rensselaer campus and at its Rensselaer Technology Park in Troy, N.Y., is designed both to help continue the advances in shrinking device dimensions seen by electronics manufacturers, and to extend this model to a wide array of industries that could benefit from nanotechnology, according to the partners.

Cadence Design Systems, an electronic design automation software company, and AMD, which makes advanced microprocessor technology and products, will collaborate with Rensselaer and IBM at the Supercomputing Center in advanced simulation and modeling of nanoelectronic devices and circuitry. The CCNI will focus on reducing the time and costs associated with designing and manufacturing nanoscale materials, devices and systems.

The center will be a resource for companies of any size — from start-ups to established firms — to perform research that needs both computing power and research expertise.

The center is expected to be operational by the end of the year.

May 10, 2006 – Both Analog Devices Inc. and ST Microelectronics announced on Tuesday that they would be supplying tri-axis MEMS accelerometers for use in Nintendo’s new home video game console, the Wii. The accelerometers will be used to provide a motion-activated user interface for the gaming machine.

The controller can detect the motion and tilt of a player’s hands in all three dimensions and convert them into game motion. Game players can execute running, jumping, spinning, sliding, steering and other moves on-screen with a single-hand, motion and tilt-activated controller, the companies said.

Nintendo had previously used a MEMS chip in its Kirby Tilt `N Tumble game for handheld Game Boy machines.

– David Forman

May 9, 2006 – Acacia Research Corp. (Nasdaq: CBMX, ACTG) announced that its CombiMatrix group has launched its next-generation CustomArray and CustomArray Synthesizer, providing researchers with the ability to fabricate the new CustomArray 90K.

The re-usable microarray has more 94,000 unique DNA probes, according to the company. It is intended to allow CombiMatrix to serve the research market with whole-genome gene expression, SNP genotyping, comparative genomic hybridization, tiling, ChIP-on-chip and resequencing.

May 8, 2006 – Owlstone Nanotech Inc., a maker of nanotech-based chemical detection products, announced it has appointed Mark Brennan to the position of executive vice president of its homeland defense division.

Brennan will be responsible for developing and executing on the strategic direction of the division, including sales and product development. Brennan was previously with Smiths Detection, where he was director of sales in the Americas division. Owlstone Nanotech is a subsidiary of Advance Nanotech Inc.

May 8, 2006 – The U.S. Senate Commerce Committee’s Subcommittee on Trade, Tourism and Economic Development heard representatives from universities, business and government describe nanotechnology as the frontier of a new global competition at a hearing on Capitol Hill Thursday.

“Nanotechnology has tremendous potential to improve the quality of life for our citizens, create high paying jobs, and increase U.S. global competitiveness,” said Sen. Gordon Smith (R-OR), who presided over the hearing. “Unfortunately, the government has not made the economic development aspect of nanotechnology much of a priority. We’re going to try to do that.”

Smith cited a program in Oregon using nano- and microtechnology in the development of Hewlett-Packard’s popular Inkjet printers as an example of the kind of economic development possible. By the year 2014 nanotechnology will affect most manufactured goods, Smith said.

Two themes emerging from the hearing were the need to meet global competition from Europe and Asia, and the opportunities offered by nanotechnology development for smaller states and areas in economic transition.

Sean Murdock, executive director of the NanoBusiness Alliance, said the U.S. faces stiff competition from abroad in the race to commercialize. The NanoBusiness Alliance estimates that more than 50 percent of firms involved with nanotechnology worldwide are based in the U.S., but announcements made at the ChinaNano2005 trade expo place the number of Chinese companies involved at 800, while a recent European Union report estimated 500 European firms active in the field

“If you were to believe statements made by the Chinese we don’t have the majority of companies” active in the field, Murdock said.

The period between a company’s formation and its producing cash flow, referred to as the “valley of death,” is especially acute for firms involved in nanotechnology, Murdock said. Early stage technology firms need adequate capital to segue from basic research to commercialization but funding from venture capital sources stung by the dot com bubble has been insufficient to promote economic development, he said.

The panel heard from leaders in public-private nanotechnology initiatives based in rural states, including Philip Boudjouk, vice president for research, creative activities and technology transfer at North Dakota State University in Fargo, N.D.; Robert “Skip” Rung, president and executive director of the Oregon Nanoscience and Microtechnolgies Institute (ONAMI) in Corvallis, Ore.; and Jerry Gwaltney, city manager of Danville, Va.

Boudjouk said the North Dakota State program has made “enormous progress” in converting research into useful products. He said research at universities should be targeted to meet commercial needs.

Rung reflected on his 25 years of experience at HP to conclude that leadership based on technological change requires “sacrificial investment, hard work — and frankly — a fair amount of stress.

“Nanotechnology…is the frontier, the battlefront, in the global innovation competition,” Rung said. “We will keep or lose our prosperity — all that that comes with — based on the outcome of this one global competition.”

Gwaltney represents a city that is using nanotechnology development to offset declines in tobacco and textiles — declines that put Danville in the unenviable position of ranking among the top four U.S. metro areas for job losses. Spurred by a public-private partnership, the city has seen its Luna nanoWorks, a division of Luna Innovations Inc., create new employment opportunities.

The panel also heard a cautionary tale from David Rejeski, director of the Woodrow Wilson Center’s Project on Emerging Nanotechnologies. Rejeski said a product accident occurred in Germany in March involving a cleanser that is called “Magic Nano.”

“The product had significant health impacts,” he said. Approximately 100 people had respiratory problems and six were hospitalized.

“Things can go wrong if we fail to provide (product) oversight,” he said. Germany’s Federal Institute for Risk Assessment is investigating the incident to determine what caused the problem and whether it had anything to do with nanotechnology.

Rejeski offered three recommendations to avoid accidents, including placing adequate research before product introductions, making sure the oversight system is transparent to the public and industry and engaging the public to build consumer confidence.

Prior to the hearing, Sen. Max Baucus (D-MT) introduced the Research Competitiveness Act of 2006, which creates a tax incentive to support investment funds that back innovative enterprises such as nanotechnology start-ups.

“This bill will help nanotechnology startup companies attract the capital they need to pass safely through the ‘valley of death’ between research and full commercialization,” said Murdock.

In October of last year, Sen. Smith introduced the Nanoscience to Commercialization Institutes Act of 2005 (S. 1908), which would provide $24 million to establish up to eight nanoscience institutes across the country to bridge the gap between research and the marketplace. An aide in Smith’s office said the senator was hopeful of getting the bill passed by the Commerce Committee and brought before the full Senate.

May 5, 2006 – Lumera Corporation (NASDAQ:LMRA) announced that it had received a purchase order from Harvard Medical School for its beta ProteomicProcessor Biosensor instrument.

Lumera is planning to place five beta units with research organizations to demonstrate and establish new applications which take advantage of the instrument’s throughput. This purchase order is the second placement of the biosensor.

May 4, 2006 – FEI Co. (Nasdaq: FEIC) turned a corner on Wednesday. The Hillsboro, Ore., maker of tools for nanoscale characterization and research announced it had cut its first quarter loss to $5.2 million, compared with a $30.7 million loss in the fourth quarter of 2005.

While that performance is still a ways off the $3.4 million first quarter profit the company posted a year ago, net sales of $113.8 million were up 12 percent over the first quarter of last year. New orders also remained strong, as the company cited a record backlog.

Analysts responded positively to the news. “We see Q1 as confirmation that the company effectively implemented its operational overhaul during 2005 to raise gross margins and overall profitability,” wrote JoAnne Feeney in a research note this morning. Feeney is an equities analyst with investment bank Punk Ziegel & Co., which makes a market in FEI stock. She reiterated a buy rating on the stock and raised her price target from $26 to $28. The stock closed today at $25.39, up 14.8 percent over yesterday’s close.

Other analysts echoed the sentiment. ThinkEquity Partners analyst Stuart Pulvirent and W.R Hambrecht analyst John Roy also raised their targets on the stock.

It was a shift that was long in coming. Prior to yesterday’s earnings announcement Feeney said the company had taken a “giant step away from the competition” through the introduction of its Titan scanning transmission electron microscope. The device began shipping in August of last year.

She was also unfazed by CEO Vahe Sarkissian’s relatively sudden departure, which was announced April 3. He had been with FEI since 1998 and had led through numerous transformations in technology. “I think Vahe was looking for retirement,” Feeney said.

FEI, which makes focused ion- and electron-beam tools for nanoscale characterization and research, is conducting a search to replace Sarkissian, who is also leaving his position on the company’s board of directors.

“We are doing a search that will include inside and outside candidates, so probably it will take several months,” said Fletcher Chamberlin, director of investor relations for the company. He would not comment on reasons for the change in leadership. He said there has been no change in the company’s strategy of focusing on three major markets: nano research, nanobiology and nanoelectronics.

In early December 2005, FEI closed its Peabody, Mass. site, where nanoelectronics instruments were made, “to focus our nanoelectronics business more tightly,” Chamberlin said.

“We concentrated those product lines back here in Hillsboro. We also had more capacity than needed.” The company will retain its Eindhoven, Netherlands site, according to Chamberlin. “It is a very significant piece of the company. That’s where we have designed and built the Titan scanning transmission electron microscope,” he said.

The Eindhoven site could also be what attracted the attention of Carl Zeiss SMT, a unit of Carl Zeiss AG, which initiated acquisition discussions with FEI several months ago. FEI terminated those discussions in February.

Analyst Feeney doesn’t think a renewed Zeiss acquisition offer is likely now that the leadership has changed hands. “My understanding is that the company as a whole rejected it,” she said.

Raymond Link, who was brought on as chief financial officer in July of last year, was recently named interim CEO while the company’s search for a new chief executive ensues.

May 4, 2006 — SEMATECH announced that Michael Lercel has been named director of the organization’s lithography division. An IBM assignee, Lercel had been serving as the division’s associate director. Lercel replaces former director Kevin Kemp, who has returned to his career at Freescale Semiconductor.

SEMATECH is dedicated to accelerating the commercialization of technology innovations into semiconductor manufacturing solutions.

May 4, 2006 – Acacia Research Corporation (Nasdaq:CBMX)(Nasdaq:ACTG) announced that its CombiMatrix group will collaborate with the Washington Animal Disease Diagnostic Laboratory influenza testing. It’s part of an effort to monitor the Pacific Flyway to determine if the seasonal migration of birds will bring the highly pathogenic Eurasian strain of Avian Influenza into North America and the United States.

The Pacific Flyway includes Alaska, Western Canada and the West Coast of the United States including Washington State.

CombiMatrix representatives say its influenza monitoring system has shown in laboratory tests that it can confirm and type the infection in four hours instead of a week, which is what many other tests take. The company is participating in this study to try and validate laboratory test results in a similar timeframe in the field.